Understand mechanisms of hemolysis โ€” intravascular vs. extravascular โ€” for ASCP BOC hematology certification.

ASCPprep.com | Hematology

Chapter 12 โ€” INTRODUCTION TO INCREASED DESTRUCTION OF ERYTHROCYTES

ASCP Board Exam ยท Lab-Focused Study Guide
Hemolytic Disorder vs Anemia ยท Classification ยท Bilirubin Metabolism ยท Haptoglobinโ€“Hemopexin System ยท Fragmentation vs Macrophage-Mediated ยท Laboratory Findings ยท Differential Diagnosis ยท Practice Questions

1 ยท Priority Table & Quick Foundation

Topic Priority Why It’s Tested
Hemolytic disorder vs hemolytic anemia (marrow compensates 6โ€“8ร—) HIGH Definition question โ€” the first item of Rodak’s review set
Fragmentation (intravascular) vs macrophage-mediated (extravascular) lab findings โ€” Table 23-2 HIGH Most-tested comparison: haptoglobin, hemoglobinuria, hemosiderinuria, spherocytes vs schistocytes
Bilirubin metabolism: unconjugated (indirect) vs conjugated (direct), urobilinogen HIGH Interpretation of bilirubin fractions and urine findings
Haptoglobinโ€“hemopexinโ€“methemalbumin salvage system HIGH Order and receptors (CD163, CD91); haptoglobin pitfalls
Classification: acute/chronic, inherited/acquired, intrinsic/extrinsic (Table 23-1) HIGH Categorize a case (e.g., acquired fragmentation)
Tests of increased erythropoiesis โ€” reticulocyte count HIGH Most commonly used test for accelerated erythropoiesis
Morphologic clues (Table 23-4): spherocytes, schistocytes, acanthocytes, burr cells, agglutination HIGH Film-to-disorder matching
Differential diagnosis vs hemorrhage, recovery, ineffective erythropoiesis (Table 23-5) HIGH Rodak Q9: why hemolysis was ruled out
Timelines of fragmentation vs macrophage-mediated hemolysis (Figure 23-7) MEDIUM Which marker appears first
Hemoglobinemia interference with CBC (falsely โ†‘ MCHC) MEDIUM Pre-analytical recognition
Glycated Hb, chromium RBC survival, endogenous CO MEDIUM Special tests
Clinical features: jaundice, gallstones, splenomegaly, bone deformities, kernicterus MEDIUM Clinical correlation
Renal handling: megalinโ€“cubilin, ferroportin in tubular cells LOW Mechanism detail
๐ŸŽฏ KEY POINT โ€” Where to spend your time

Focus: Table 23-2 (fragmentation vs macrophage-mediated), bilirubin fractions and urine urobilinogen, the haptoglobin โ†’ hemopexin โ†’ methemalbumin order, reticulocyte count as the key production marker, and how hemorrhage/recovery/megaloblastic anemia differ from hemolysis. Skim: renal megalinโ€“cubilin details, chromium half-time numbers, CO measurement.

Quick Foundation โ€” from zero

  • Hemolysis = red cells destroyed faster than their normal ~120-day life span.
  • A healthy marrow can raise output 6โ€“8 times. If it keeps up, the patient has a hemolytic disorder without anemia. If destruction outpaces production, it becomes a hemolytic anemia.
  • Cells die in two ways: macrophages eat them (macrophage-mediated/extravascular โ€” mainly spleen and liver) or they are torn apart in the circulation (fragmentation/intravascular), spilling hemoglobin into the plasma.
  • Both routes break heme into iron (recycled) and bilirubin, so jaundice and urine urobilinogen rise.
  • Free plasma hemoglobin is mopped up by haptoglobin, then hemopexin, then albumin; when these are overwhelmed, hemoglobin spills into the urine.
  • The marrow responds with reticulocytes, the main sign that production is increasing.
๐Ÿ’ก Analogy

Think of a recycling plant. Normally old cars (RBCs) are towed to the plant (macrophages) and dismantled cleanly. Macrophage-mediated hemolysis = too many cars towed in โ€” the plant is busy but the streets stay clean. Fragmentation hemolysis = cars crash on the highway โ€” debris (hemoglobin) spills onto the road, and street sweepers (haptoglobin, hemopexin) are used up; when they run out, debris washes into the drains (urine).

๐Ÿฅ Why this matters clinically

Deciding where cells are destroyed narrows the cause: schistocytes and hemoglobinuria point to prosthetic valves, TTP/DIC, malaria or transfusion reactions; spherocytes point to hereditary spherocytosis or warm autoimmune hemolysis. The later chapters build on this sorting.

Concept Plain-English Explanation
Hemolytic disorder โ†‘ RBC destruction with compensatory โ†‘ production (may or may not have anemia)
Hemolytic anemia Destruction exceeds the marrow’s increased production
Macrophage-mediated (extravascular) RBCs engulfed and lysed by macrophages, mostly spleen and liver
Fragmentation (intravascular) RBC membrane torn, contents spill into plasma
Unconjugated (indirect) bilirubin Water-insoluble bilirubin on albumin, from heme breakdown
Conjugated (direct) bilirubin Water-soluble bilirubin diglucuronide made in the liver
Hemoglobinemia / hemoglobinuria Free hemoglobin in plasma / urine
Hemosiderinuria Iron (hemosiderin) in shed renal tubular cells in urine

2 ยท Core Content Tables

2.1 Hemolytic Disorder vs Hemolytic Anemia

Feature Details
Hemolytic disorder โ†‘ rate of RBC destruction (shortened life span) โ†’ โ†“ Oโ‚‚ โ†’ โ†‘ EPO โ†’ accelerated production โ†’ reticulocytosis. Present without anemia when the marrow compensates
Marrow capacity Can increase 6โ€“8ร— normal โ€” significant destruction is needed before anemia develops
Hemolytic anemia Rate of destruction exceeds the increased rate of production
Secondary hemolytic component Bโ‚โ‚‚/folate deficiency, anemia of chronic inflammation, renal disease, iron deficiency โ€” hemolysis isn’t the primary cause, so they aren’t classified as hemolytic disorders

2.2 Classification Schemes

Feature Details
Acute vs chronic Acute: rapid, isolated, episodic or paroxysmal (paroxysmal cold hemoglobinuria after cold exposure; PNH episodes; hemolytic transfusion reaction). Chronic: may be compensated, punctuated by crises (G6PD deficiency after antimalarials) or so severe the marrow can’t keep up (thalassemia โ€” excess chains precipitate)
Inherited vs acquired Inherited = mutant genes; acquired = previously normal person acquires an agent/condition (e.g., malaria)
Intrinsic Defect in the RBC (membrane, enzymes, hemoglobin). Patient’s cells transfused into a healthy person โ†’ still short survival; normal cells in the patient โ†’ normal survival. Mostly inherited
Extrinsic Cause outside the RBC (antibodies, prosthetic valves, microangiopathy, infections, drugs, venoms, physical agents). Normal cells transfused into the patient โ†’ short survival. Mostly acquired. Malaria counts as extrinsic (RBC normal until invaded)
Exception PNH โ€” acquired disorder with an intrinsic defect
Mechanistic Fragmentation (intravascular) vs macrophage-mediated (extravascular) โ€” the basis of screening test differences

2.3 Hemolytic Anemias by Cause and Mechanism (Rodak Table 23-1)

Category Predominantly Fragmentation (Intravascular) Predominantly Macrophage-Mediated (Extravascular)
Extrinsic โ€” agents outside the RBC (acquired) Immune: cold antibody ยท microangiopathic hemolysis ยท infectious (malaria) ยท thermal injury ยท chemicals/drugs ยท venoms ยท prosthetic heart valve (chronic) Immune: warm antibody ยท drugs
Membrane abnormalities Spur cell anemia of severe liver disease (chronic) ยท PNH Hereditary membrane defects (chronic)
Intrinsic โ€” RBC interior (hereditary) Enzyme defects (G6PD deficiency โ€” acute/episodic) ยท globin abnormalities (sickle cell, thalassemia โ€” chronic) โ€”

Most hereditary conditions cause chronic hemolysis; acquired conditions are more often acute. Intrinsic defects are usually hereditary, extrinsic usually acquired. Some conditions show mixed mechanisms.

2.4 Normal Heme Catabolism & Bilirubin Metabolism

Feature Details
Normal destruction RBCs live ~120 days; aged cells lose deformability; macrophages (mainly spleen and liver, also marrow, nodes, monocytes) phagocytize them
In the macrophage Hb โ†’ heme + globin. Globin โ†’ amino acids (reused). Heme โ†’ iron (via ferroportin โ†’ transferrin โ†’ reused) + protoporphyrin
Protoporphyrin Heme oxygenase opens the ring โ†’ biliverdin (green) + CO (exhaled) โ†’ biliverdin reductase โ†’ unconjugated bilirubin (yellow, nonpolar)
Transport Unconjugated bilirubin binds albumin โ†’ liver sinusoid โ†’ enters hepatocyte (possibly OAT proteins)
Conjugation Glucuronyl transferase adds 2 glucuronic acids โ†’ bilirubin diglucuronide = conjugated (direct), water soluble
Excretion Bile โ†’ intestine (fat emulsification) โ†’ gut bacteria โ†’ urobilinogen โ†’ most oxidized to stercobilin (brown stool)
Recycling Some urobilinogen/conjugated bilirubin reabsorbed via portal circulation โ†’ mostly re-excreted in bile; a little filtered โ†’ urine urobilinogen normal; urine bilirubin normally negative. Yellow urine = urobilin
Color changes (bruise) Purple-red (Hb) โ†’ green (biliverdin) โ†’ yellow (bilirubin)
Test Principle Reference (Box 23-2)
Total bilirubin Diazotized sulfanilic acid + solubilizing reagent (alcohol) โ†’ both forms react 0.5โ€“1.0 mg/dL
Direct (conjugated) Reacts directly with aqueous reagent (polar) 0โ€“0.2 mg/dL
Indirect (unconjugated) Calculated: total โˆ’ direct (needs solubilizer to react) 0โ€“0.8 mg/dL
๐Ÿงช PRE-ANALYTICAL โ€” Bilirubin & hemolysis markers*
  • Protect bilirubin specimens from light (photodegradation falsely lowers results)
  • In-vitro hemolysis (difficult draw, small needle, vigorous mixing) raises plasma Hb, LDH and potassium and can mimic intravascular hemolysis โ€” Rodak notes a properly collected specimen has plasma Hb <1 mg/dL
  • Hemolyzed samples interfere with many bilirubin methods

2.5 Normal Plasma Hemoglobin Salvage (Haptoglobinโ€“Hemopexinโ€“Methemalbumin System)

Feature Details
Normal fragmentation 10โ€“20% of normal RBC destruction (turbulence, vascular restriction)
Why salvage Prevents urinary iron loss and oxidative damage by free Hb/heme
1 ยท Haptoglobin (first) Liver protein; binds Hb ฮฑฮฒ dimers (‘pseudotetramer’); complex binds CD163 on macrophages (liver, spleen, marrow, lung) โ†’ internalized; globin catabolized, iron salvaged, protoporphyrin โ†’ unconjugated bilirubin; haptoglobin degraded (not recycled)
2 ยท Hemopexin (second) Free Hb is rapidly oxidized โ†’ methemoglobin โ†’ metheme (hemin) dissociates โ†’ binds hemopexin โ†’ CD91 (LRP1) on hepatocytes โ†’ internalized; hemopexin mostly recycled
3 ยท Methemalbumin (third) Albumin temporarily holds metheme (high plasma concentration) until transferred to hemopexin (higher affinity)
Kidney Overflow Hb/metheme filtered โ†’ proximal tubular cells reabsorb (megalinโ€“cubilin), heme oxygenase-1 frees iron โ†’ ferroportin exports it; excess stored as ferritin/hemosiderin
Therapeutic note (Box 23-4) Haptoglobin used therapeutically in Japan since 1985; hemopexin under investigation
๐Ÿงช PRE-ANALYTICAL โ€” Hemoglobinemia and the CBC (Box 23-3)
  • With significant hemoglobinemia, the analyzer measures intracellular plus plasma Hb โ†’ falsely high Hb
  • Clue: an unrealistically high MCHC
  • Plasma is not visibly red/brown until plasma Hb reaches ~50 mg/dL, so a clear plasma doesn’t exclude hemolysis

2.6 Excessive Macrophage-Mediated (Extravascular) Hemolysis

Feature Details
Mechanism Defective cells display senescence-like markers โ†’ removed by macrophages (spleen, liver). Examples: Heinz bodies (oxidized Hb), intracellular parasites, complement or immunoglobulin on the surface
Where lysed Inside a phagolysosome โ€” contents not released to plasma
Spherocyte formation Macrophage removes part of the membrane; cell reseals with little cytoplasm lost โ†’ less membrane โ†’ spherocyte; rigid, trapped at next splenic passage
Bilirubin โ†‘ total bilirubin from โ†‘ unconjugated fraction; conjugated stays within reference if liver is healthy
Urobilinogen โ†‘ in stool and urine; no urine bilirubin (unconjugated bilirubin is albumin-bound, not filtered)

2.7 Excessive Fragmentation (Intravascular) Hemolysis

Feature Details
Examples Prosthetic heart valves, exit of malaria parasites, microangiopathy โ€” can cause profound anemia
Plasma (Met)hemoglobinemia; Hbโ€“haptoglobin, methemeโ€“hemopexin, methemeโ€“albumin complexes form
Haptoglobin Decreased/absent โ€” complexes cleared; no compensatory rise in production
Hemopexin Decreases (recycling saturated), but less dramatically than haptoglobin
Urine Hemoglobinuria when salvage capacity exceeded; hemosiderinuria later (tubular cells shed with iron)
Bilirubin and urobilinogen Also โ†‘, but take time to appear

2.8 Fragmentation vs Macrophage-Mediated โ€” Laboratory Findings (Rodak Table 23-2)

Specimen Result Fragmentation Macrophage-Mediated
Serum Total bilirubin โ†‘ โ†‘
Indirect (unconjugated) bilirubin โ†‘ โ†‘
Direct (conjugated) bilirubin WRI WRI
LDH (RBC fraction) โ†‘ sl โ†‘
Haptoglobin โ†“ sl โ†“
Free hemoglobin โ†‘ sl โ†‘
Hemopexin โ†“ sl โ†“
Urine Urobilinogen โ†‘ โ†‘
Free hemoglobin Positive Negative
Methemoglobin Positive Negative
Prussian blue urine sediment (hemosiderin) Positive Negative
Whole blood Hb, Hct, RBC โ†“ โ†“
Schistocytes Often present โ€”
Spherocytes โ€” Often present
Glycated hemoglobin โ†“ โ†“
Special Endogenous carbon monoxide โ†‘ โ†‘
Erythrocyte life span โ†“ โ†“

โ†‘ increased ยท โ†“ decreased ยท sl = slightly (minor component) ยท WRI = within reference interval. Macrophage-mediated hemolysis may include a minor fragmentation component (fragile spherocytes lysing in the spleen).

2.9 Clinical Features

Feature Details
Anemia symptoms Fatigue, dyspnea, dizziness; pallor, tachycardia
Jaundice Yellow skin and sclera from โ†‘ plasma bilirubin; icterus = plasma/tissues. Hemolytic (prehepatic) jaundice = predominance of unconjugated bilirubin
Kernicterus Newborns: lipid-soluble unconjugated bilirubin deposits in the brain (immature blood-brain barrier)
Pattern clue G6PD deficiency: periodic jaundice after crises ยท thalassemia: chronic ยท hereditary elliptocytosis: may be absent
Chronic hemolysis Splenomegaly (macrophage-mediated) ยท gallstones (cholelithiasis from โ†‘ bile bilirubin) ยท children: bone deformities from marrow hyperplasia
Acute hemolysis Malaise, aches, vomiting, fever (mimics infection); fragmentation: prostration, shock, flank pain, oliguria/anuria โ†’ acute renal failure
Brown urine (Met)hemoglobinuria โ†’ fragmentation

2.10 Tests of Accelerated RBC Destruction

Feature Details
Plasma/urine color Methemoglobin, methemalbumin and hemopexin-heme โ†’ coffee-brown plasma; urine ‘root beer‘/’beer’ colored โ†’ fragmentation. Normal plasma Hb <1 mg/dL; visibly red/brown at ~50 mg/dL; hemolysis may raise it to only 15 mg/dL (not visible)
Urine strip Positive for blood even without visible color; sediment negative for RBCs; Prussian blue stain of tubular cells โ†’ hemosiderin
Film Spherocytes (macrophage-mediated) vs schistocytes (fragmentation); ring forms (malaria), sickle cells, target cells/microcytes (thalassemia)
Bilirubin โ†‘ unconjugated; conjugated WRI if liver normal; no urine bilirubin; โ†‘ urine urobilinogen. Total bilirubin can stay normal if hemolysis is low and the liver is healthy โ€” fecal urobilinogen would still rise
Haptoglobin Substantial โ†“ โ†’ fragmentation (low Hp had 87% probability of hemolysis in one study). Pitfalls: false low in liver disease (โ†“ synthesis); false normal with infection/inflammation (acute phase reactant)
Hemopexin May be low but rarely measured
Carbon monoxide 2โ€“10ร— normal endogenous CO production in hemolytic anemia; not routinely used
LDH โ†‘ from ruptured RBCs; also โ†‘ in MI and liver disease โ€” isoenzymes usually not needed
Glycated Hb (Hb Aโ‚c) โ†“ with shortened RBC survival (mean 6.7% โ†’ 3.9% in one hemolysis report; reflects prior 4โ€“8 weeks); unreliable in diabetes
Chromium-51 RBC survival Reference method (ICSH), random labeling; normal half-time 25โ€“32 days; 20โ€“25 mild, 15โ€“20 moderate, <15 severe hemolysis; research use mainly

2.11 Tests of Increased Erythropoiesis (Table 23-3)

Feature Details
Timing Evident 3โ€“6 days after an acute hemolytic episode; persistent in chronic hemolysis. Not unique to hemolysis (also after hemorrhage and treated deficiency)
Reticulocyte count Most commonly used test; โ†‘ absolute retic, relative retic, RPI, immature reticulocyte fraction. If anemia + reticulocytosis and hemorrhage is ruled out โ†’ investigate hemolysis
Exceptions Aplastic crises; immunohemolytic anemias targeting marrow precursors
Film Polychromasia, nucleated RBCs
MCV Rises vs the patient’s baseline (large shift retics) โ€” may stay within reference; can stay low with microspherocytes (HS), schistocytes (burns)
Other Leukocytosis and thrombocytosis may accompany acute hemolysis; โ†“ platelets with hemolysis suggests a platelet-consuming microangiopathy (e.g., DIC)
Bone marrow Usually unnecessary; erythroid hyperplasia โ†’ โ†“ M:E ratio; cellularity judged on core biopsy

2.12 Morphologic Abnormalities in Hemolytic Anemia (Rodak Table 23-4)

RBC Morphology Hemolytic Disorders
Spherocytes Hereditary spherocytosis, IgG-mediated immune hemolysis, thermal injury
Elliptocytes (ovalocytes) Hereditary elliptocytosis
Acanthocytes Abetalipoproteinemia, severe liver disease (spur cell anemia)
Burr cells Pyruvate kinase deficiency, uremia
Schistocytes Microangiopathic, macroangiopathic (traumatic cardiac), IgM-mediated immune hemolysis
Erythrophagocytosis RBC surface damage, especially complement-fixing antibodies
RBC agglutination Cold agglutinins, immunohemolytic disease

Specific follow-up tests (later chapters): DAT, osmotic fragility, EMA binding, Heinz body test, enzyme studies, serologic tests, immunophenotyping.

*From general laboratory practice, not stated in Rodak Ch. 23.

3 ยท Visual Memory Hooks

๐Ÿง  Disorder vs anemia
โ€œDisorder = destruction; Anemia = destruction winsโ€ (marrow can run 6โ€“8ร— faster).
๐Ÿง  Intrinsic vs extrinsic
โ€œIntrinsic Inherited, Extrinsic Earnedโ€ โ€” PNH is the exception (acquired intrinsic).
๐Ÿง  Two routes
โ€œEaten or Explodedโ€ โ†’ macrophage-mediated (extravascular) or fragmentation (intravascular).
๐Ÿง  Film clue
โ€œSpheres are Spit out by the Spleen; Schistocytes are Shredded in vesselsโ€.
๐Ÿง  Heme breakdown
โ€œHeme โ†’ Bili-VERDE (green) โ†’ Bili-RUBIN (red-yellow)โ€; CO exhaled.
๐Ÿง  Bilirubin fractions
โ€œDirect = Dissolved (conjugated, water-soluble); Indirect = Insoluble (needs alcohol)โ€.
๐Ÿง  Urine rule
โ€œUnconjugated can’t Urinateโ€ โ†’ no urine bilirubin in hemolysis; urobilinogen โ†‘.
๐Ÿง  Salvage order
โ€œHap, then Hex, then Albuminโ€ โ†’ haptoglobin โ†’ hemopexin โ†’ methemalbumin.
๐Ÿง  Receptors
โ€œHapto โ†’ CD163 macrophages; Hemo โ†’ CD91 hepatocytesโ€.
๐Ÿง  Urine sequence
โ€œHemoglobin first, Hemosiderin laterโ€.
๐Ÿง  Haptoglobin traps
โ€œLow in Liver disease, Normal in iNflammationโ€.
๐Ÿง  Colors
โ€œCoffee plasma, Root-beer urine = fragmentationโ€.
๐Ÿง  Timeline
โ€œFragmentation shows up Fast; Macrophage waits for bilirubin and reticsโ€.
๐Ÿง  Most used production test
โ€œRetics Report the Responseโ€.
๐Ÿง  Not hemolysis
โ€œRetics without bilirubin = bleeding recovery or treated deficiency; bilirubin without retics = ineffective erythropoiesisโ€.

Pattern Triggers

If you seeโ€ฆ Thinkโ€ฆ Becauseโ€ฆ
Reticulocytosis, โ†‘ indirect bilirubin, normal Hb Compensated hemolytic disorder Marrow keeping up (up to 6โ€“8ร—)
Root beer-colored urine, blood strip +, no RBCs in sediment, โ†“โ†“ haptoglobin Fragmentation (intravascular) hemolysis Free Hb exceeded salvage capacity
Schistocytes + โ†“ platelets Microangiopathic hemolysis (e.g., DIC, TTP) Platelet consumption + RBC shearing
Spherocytes, โ†‘ indirect bilirubin, โ†‘ urine urobilinogen, no hemoglobinuria Macrophage-mediated hemolysis Contents stay inside macrophages
Prussian blue + urine sediment days after an event Recent/chronic fragmentation hemolysis Hemosiderin in shed tubular cells
Very high MCHC, visibly hemolyzed plasma Hemoglobinemia interference Analyzer adds plasma Hb
Low haptoglobin, no other signs, cirrhosis Decreased hepatic synthesis, not hemolysis False positive
Normal haptoglobin in a febrile patient with hemolysis signs Acute phase increase masking consumption False negative
โ†‘ direct bilirubin Hepatic/obstructive process, not hemolysis alone Hemolysis raises the indirect fraction
Hb falling ~1 g/dL per week, jaundice, retics โ†‘, no bleeding Hemolytic anemia Rapid drop + destruction markers
Slow Hb decline, โ†‘ retics, normal bilirubin and urobilinogen Not hemolytic (e.g., blood loss or production problem) No evidence of protoporphyrin catabolism
โ†‘ indirect bilirubin + LDH, โ†“ retics, macrocytes Ineffective erythropoiesis (megaloblastic) Cells die in the marrow
Retics โ†‘ and bilirubin โ†‘ after internal bleeding Hemorrhage into a body cavity Catabolism of pooled RBCs; normal morphology
Low Hb Aโ‚c in a nondiabetic anemic patient Shortened RBC survival Less glucose exposure time

Commonly Confused Pairs

Feature A B
Hemolytic disorder vs hemolytic anemia Destruction compensated Destruction exceeds production
Intrinsic vs extrinsic Defect in RBC; patient’s cells die in normal hosts Outside agent; normal cells die in patient
Fragmentation vs macrophage-mediated Schistocytes; hemoglobinuria; โ†“โ†“ Hp Spherocytes; no hemoglobinuria; slight โ†“ Hp
Unconjugated vs conjugated bilirubin Indirect; albumin-bound; not in urine Direct; water soluble; bile
Haptoglobin vs hemopexin Binds Hb dimers; CD163; degraded Binds metheme; CD91; mostly recycled
Hemoglobinuria vs hematuria Free Hb; no RBCs in sediment Intact RBCs in sediment
Hemoglobinuria vs hemosiderinuria Acute, as salvage is exceeded Later; tubular cells with iron
Biliverdin vs bilirubin Green, first product Yellow, after reductase
Urobilinogen vs urobilin Colorless Yellow urine color
Hemolysis vs recovery from hemorrhage Retics + bilirubin Retics without bilirubin
Hemolysis vs megaloblastic anemia โ†‘ retics โ†“ retics despite โ†‘ bilirubin/LDH

Timeline Table (Figure 23-7)

Marker Fragmentation โ€” Onset/Peak Macrophage-Mediated Duration Best Exam Use
Whole blood Hb Falls immediately Falls gradually Until recovery Rapid drop (~1 g/dL/week) suggests hemolysis
Plasma Hb Very soon; peaks within ~1 day Not present (slight) Disappears when hemolysis ends Earliest fragmentation sign
Urinary Hb Shortly after plasma Hb Negative Resolves as Hp returns Salvage exceeded
Serum haptoglobin Drops as plasma Hb rises Slight drop Returns to normal after hemolysis ends Fragmentation marker
Hemosiderinuria Days later Negative Persists Recent/chronic fragmentation
Plasma bilirubin Rises after the event (~days 2โ€“4) Delayed rise Persists while hemolysis continues Needs time to form
Reticulocytes Several days later (3โ€“6 d) Several days later Persistent in chronic Marrow response
Cr-51 half-time โ€” โ€” Normal 25โ€“32 d; <15 d severe RBC survival reference method

4 ยท Diagnostic Flowcharts

Flowchart 1 โ€” Is this anemia hemolytic? (Differential Diagnosis)

Anemia โ†’ Rapid Hb drop (e.g., 1 g/dL/week) with hemorrhage and hemodilution ruled out?
Yes + jaundice + reticulocytosis โ†’ Hemolytic cause likely
Only indirect bilirubin โ†‘, urine urobilinogen โ†‘ โ†’ Confirms hemolytic (prehepatic) jaundice
Reticulocytosis without bilirubinemia โ†’ Recovery from hemorrhage or treated iron/Bโ‚โ‚‚/folate deficiency
Bilirubinemia with low retic โ†’ Ineffective erythropoiesis (e.g., megaloblastic anemia)
โš ๏ธ Common mistake: calling every reticulocytosis ‘hemolysis’. Recovery from bleeding or treatment also raises retics โ€” but without bilirubinemia.

Flowchart 2 โ€” Fragmentation or macrophage-mediated?

Hemolysis confirmed โ†’ Plasma/urine color, urine Hb, haptoglobin, film
Hemoglobinemia, hemoglobinuria, โ†“โ†“ haptoglobin, schistocytes โ†’ Fragmentation โ†’ valves, microangiopathy, malaria, cold antibody, burns, venoms, G6PD
Hemosiderin on Prussian blue urine sediment โ†’ Recent/chronic fragmentation
No plasma/urine Hb, slight โ†“ Hp, spherocytes โ†’ Macrophage-mediated โ†’ warm antibody, hereditary membrane defects, drugs
Next โ†’ Specific tests: DAT, osmotic fragility, EMA, Heinz body, enzymes
โš ๏ธ Common mistake: using a low haptoglobin alone. Liver disease lowers it and inflammation raises it โ€” combine with urine and film findings.

Flowchart 3 โ€” Timing after an acute hemolytic event

Hours โ†’ Plasma Hb โ†‘, haptoglobin โ†“, hemoglobinuria (fragmentation)
Days 2โ€“4 โ†’ Indirect bilirubin rises; urine urobilinogen โ†‘
Days 3โ€“6 โ†’ Reticulocytosis, polychromasia; MCV rises vs baseline
Days later โ†’ Hemosiderinuria
After hemolysis stops โ†’ Plasma/urine Hb disappear; haptoglobin returns; bilirubin/retics still rise
โš ๏ธ Common mistake: expecting reticulocytosis on day 1. The marrow response lags 3โ€“6 days.

Flowchart 4 โ€” Classify the case (Rodak Q6 logic)

5-year-old, pneumonia, dark urine, mild anemia, polychromasia, schistocytes, no family history โ†’ Onset?
Previously normal, triggered by illness โ†’ Acquired
Dark urine + schistocytes โ†’ Fragmentation
Category โ†’ Acquired, fragmentation hemolysis
โš ๏ธ Common mistake: calling it hereditary because the patient is a child.

Flowchart 5 โ€” Test selection for suspected hemolysis

Screen destruction โ†’ Total/indirect bilirubin, LDH, haptoglobin, urine urobilinogen, urine Hb, plasma Hb
Screen production โ†’ Reticulocyte count (absolute, RPI, IRF), film for polychromasia/nRBCs
Localize mechanism โ†’ Film (spherocytes vs schistocytes), urine Prussian blue
Survival research/special โ†’ Cr-51 survival, endogenous CO, glycated Hb
Etiology โ†’ DAT, osmotic fragility, EMA, Heinz bodies, enzyme assays, serology, flow
โš ๏ธ Common mistake: ordering a bone marrow โ€” rarely needed; it just shows erythroid hyperplasia.

5 ยท 25 High-Yield Facts

# Fact
1 A hemolytic disorder is increased RBC destruction with compensatory increased production.
2 Hemolytic anemia develops when destruction exceeds the marrow’s increased production.
3 A healthy marrow can increase RBC production six to eight times normal.
4 Intrinsic defects are usually inherited; extrinsic defects are usually acquired.
5 PNH is an acquired hemolytic disorder with an intrinsic RBC defect.
6 Malaria is classified as extrinsic because the RBC was normal before invasion.
7 Normally most RBCs are destroyed by macrophages in the spleen and liver.
8 About 10โ€“20% of normal RBC destruction is by fragmentation.
9 Heme oxygenase converts heme to biliverdin, releasing iron and carbon monoxide.
10 Biliverdin reductase converts biliverdin to unconjugated bilirubin, which travels on albumin.
11 Glucuronyl transferase in the liver forms conjugated (direct) bilirubin diglucuronide.
12 Gut bacteria convert conjugated bilirubin to urobilinogen; stercobilin colors stool brown.
13 Unconjugated bilirubin is not excreted in urine because it is bound to albumin.
14 Haptoglobin binds hemoglobin dimers and is cleared by CD163 on macrophages.
15 Hemopexin binds metheme and is cleared by CD91 on hepatocytes.
16 Methemalbumin is a temporary carrier until metheme transfers to hemopexin.
17 Fragmentation hemolysis causes hemoglobinemia, hemoglobinuria and later hemosiderinuria.
18 Haptoglobin is markedly decreased in fragmentation hemolysis.
19 Haptoglobin can be falsely low in liver disease and falsely normal in inflammation.
20 Macrophage-mediated hemolysis often shows spherocytes; fragmentation shows schistocytes.
21 Elevated urine urobilinogen occurs in both fragmentation and macrophage-mediated hemolysis.
22 The reticulocyte count is the most commonly used test of accelerated erythropoiesis.
23 Increased erythropoiesis is evident 3โ€“6 days after an acute hemolytic episode.
24 Significant hemoglobinemia falsely raises the measured Hb and MCHC.
25 Chronic hemolysis may cause splenomegaly, gallstones and, in children, bone deformities.
โญ EXAM TIP โ€” The single most testable pattern

Both routes: โ†‘ indirect bilirubin, โ†‘ urine urobilinogen, โ†‘ retics, normal direct bilirubin. Only fragmentation: hemoglobinemia, hemoglobinuria, hemosiderinuria, โ†“โ†“ haptoglobin, schistocytes. Macrophage-mediated: spherocytes, urine Hb negative.

Quick Interpretation Table

Lab Finding Clinical Interpretation
Post-op day 3: root beer urine, Hb 5.8 g/dL (normal pre-op), no bleeding Acute fragmentation hemolysis โ†’ expect โ†‘ plasma Hb, โ†“ Hp, hemoglobinuria, โ†‘ LDH, later โ†‘ bilirubin and retics
โ†‘ Total and indirect bilirubin, โ†‘ urine urobilinogen, โ†“ Hp, โ†‘ retics, spherocytes, family history Chronic macrophage-mediated hemolysis (inconsistent with fragmentation: spherocytes)
โ†“ Hp, urine Hb +, Prussian blue urine + Chronic fragmentation hemolysis
โ†‘ Retics, normal bilirubin and urine urobilinogen, slow Hb decline Not hemolytic
โ†‘ Direct bilirubin, urine bilirubin + Hepatic or obstructive jaundice
Cr-51 half-time 12 days Severe hemolysis
MCHC 39 g/dL with visible hemolysis Hemoglobinemia interference

๐ŸŽด Flashcards โ€” Active Recall Practice

How it works: tap the card to flip it. Then mark it โœ“ Knew It or โœ— Review Again (buttons unlock after flipping). Use ๐Ÿ”€ Shuffle to randomize and ๐Ÿ Finish anytime โ€” your summary appears at the end, and you can drill only the cards you missed.

๐Ÿ“ Practice Quiz โ€” Test Your Knowledge

How it works: tap an answer for each case. You’ll get instant feedback with the full explanation and the examiner’s trap. Your final score appears once all 10 are answered.

๐Ÿชค Trap Questions โ€” Beat the Examiner

Harder on purpose. Each question targets a real misconception. After answering you’ll see the correct reasoning, the trap explained, why the examiner wrote it, and the wrong answer most students choose.

8 ยท Rapid Revision Sheet

๐Ÿ“– READ THIS 2 HOURS BEFORE YOUR EXAM

Definitions

  • Disorder: โ†‘ destruction + โ†‘ production
  • Anemia: destruction > production
  • Marrow up to 6โ€“8ร—
  • Normal fragmentation 10โ€“20%

Classification

  • Acute (paroxysmal) vs chronic
  • Inherited vs acquired
  • Intrinsic (mostly inherited) vs extrinsic (mostly acquired)
  • PNH = acquired intrinsic
  • Fragmentation vs macrophage-mediated

Heme โ†’ Bilirubin

  • Heme oxygenase โ†’ biliverdin + Fe + CO
  • Biliverdin reductase โ†’ unconjugated (albumin)
  • Glucuronyl transferase โ†’ diglucuronide (direct)
  • Gut โ†’ urobilinogen โ†’ stercobilin
  • Urine yellow = urobilin

Bilirubin Numbers

  • Total 0.5โ€“1.0 mg/dL
  • Direct 0โ€“0.2 mg/dL
  • Indirect 0โ€“0.8 mg/dL (total โˆ’ direct)
  • Hemolysis: โ†‘ indirect, direct WRI
  • Urine bilirubin negative

Salvage System

  • Haptoglobin โ†’ Hb dimers โ†’ CD163 (macrophages) โ†’ degraded
  • Hemopexin โ†’ metheme โ†’ CD91 (hepatocytes) โ†’ recycled
  • Albumin โ†’ methemalbumin (temporary)
  • Kidney: megalinโ€“cubilin โ†’ hemosiderin

Fragmentation Only

  • โ†‘ Plasma Hb (coffee-brown)
  • Hemoglobinuria (root beer)
  • Hemosiderinuria (Prussian blue)
  • โ†“โ†“ Haptoglobin ยท โ†‘ LDH
  • Schistocytes

Macrophage-Mediated

  • Spherocytes
  • Urine Hb negative
  • Slight โ†“ Hp, slight โ†‘ LDH
  • โ†‘ Indirect bili, โ†‘ urobilinogen
  • Splenomegaly in chronic

Special Tests

  • Plasma Hb normal <1 mg/dL ยท visible ~50
  • Low Hp: 87% probability of hemolysis
  • Glycated Hb โ†“ (6.7 โ†’ 3.9%)
  • Cr-51 half-time 25โ€“32 d (<15 severe)
  • CO 2โ€“10ร— normal

Confusing Pairs

  • Hemoglobinuria โ‰  hematuria (no RBCs)
  • Hemoglobinuria (early) โ‰  hemosiderinuria (late)
  • Hp (Hb dimers) โ‰  hemopexin (heme)
  • Hp false โ†“ liver ยท false N inflammation
  • โ†‘ MCHC = hemoglobinemia artifact

Differential (Table 23-5)

  • Hemolysis: โ†“Hb + bili + retics
  • Hemorrhage/dilution: no bili, no retics (early)
  • Recovery/treated deficiency: retics, no bili
  • Body cavity bleed: delayed bili + retics, normal RBCs
  • Ineffective: bili, no retics

9 ยท Final Memory Map

  • ๐Ÿ’ฅ INCREASED RBC DESTRUCTION
    • Definitions
      • Hemolytic disorder vs hemolytic anemia
      • Secondary hemolytic component (Bโ‚โ‚‚, ACI, renal, iron)
    • Classification
      • Acute/chronic ยท inherited/acquired
      • Intrinsic (membrane, enzyme, globin) vs extrinsic (immune, mechanical, infectious, chemical)
      • Fragmentation vs macrophage-mediated
    • Normal Catabolism
      • Macrophage: Hb โ†’ heme + globin โ†’ iron + bilirubin
      • Liver conjugation ยท gut urobilinogen ยท urine urobilin
    • Salvage System
      • Haptoglobin โ†’ CD163
      • Hemopexin โ†’ CD91
      • Methemalbumin ยท kidney hemosiderin
    • Fragmentation
      • Hemoglobinemia/uria, hemosiderinuria
      • โ†“โ†“ Hp, โ†‘ LDH, schistocytes
    • Macrophage-Mediated
      • Spherocytes ยท no urine Hb
      • โ†‘ indirect bilirubin, โ†‘ urobilinogen
    • Clinical
      • Jaundice (prehepatic), kernicterus
      • Splenomegaly, gallstones, bone deformities
      • Acute renal failure in fragmentation
    • Laboratory
      • Destruction: bilirubin, Hp, LDH, urine, film, CO, Hb Aโ‚c, Cr-51
      • Production: retics, polychromasia, nRBCs, marrow hyperplasia
      • Specific: DAT, osmotic fragility, EMA, Heinz, enzymes
    • Differential
      • Hemorrhage, hemodilution, recovery, body-cavity bleed, ineffective erythropoiesis



PreviousNext